Loading…

How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?

The current pandemic coronavirus, SARS-CoV-2, is known to cause severe infection (COVID-19) in patients with comorbidities, particularly cancer or an immunosuppressed state. Most healthcare systems in the country are likely to be overwhelmed soon if the pandemic moves to a stage of community transmi...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of hematology & blood transfusion 2020-10, Vol.36 (4), p.605-615
Main Authors: Jain, Arihant, Singh, Charanpreet, Dhawan, Rishi, Jindal, Nishant, Mohindra, Ritin, Lad, Deepesh, Prakash, Gaurav, Khadwal, Alka, Suri, Vikas, Bhalla, Ashish, Kumari, Savita, Varma, Neelam, John, M Joseph, Mahapatra, Manoranjan, Malhotra, Pankaj
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The current pandemic coronavirus, SARS-CoV-2, is known to cause severe infection (COVID-19) in patients with comorbidities, particularly cancer or an immunosuppressed state. Most healthcare systems in the country are likely to be overwhelmed soon if the pandemic moves to a stage of community transmission. Currently, limited evidence is available for managing patients with hematological disorders during the COVID-19 pandemic. The current review summarises the possible challenges clinicians are likely to face, key considerations to guide decision making, and possible solutions to the anticipated challenges. Disease specific recommendations and possible guidance for decision making have been suggested for most hematologic diseases that are feasible in our health setup. It is not meant to replace individual clinical judgment, but to provide a template to formulate local policies.
ISSN:0971-4502
0974-0449
0974-0449
0971-4502
DOI:10.1007/s12288-020-01300-0